CBD-Rich cannabis products associated with improvements for patients with severe pain, anxiety and depression.

CONTEXT:  Publication of a real-world evidence study in the Journal of Cannabis Research points to improvements in patients with moderate to severe pain, anxiety or depression.  A group of 279 Canadian patients were assessed over a 6-month period.  The moderate to severe patients saw improvement in symptoms whereas the patients with mild symptoms saw little overall change.  

READ TIME:  1 min

1. “A team of Canadian researchers assessed the use of lab-tested, CBD-rich products over a six-month period in a cohort of 279 subjects with mild to severe symptoms. ” 

2. “Study: CBD-Rich Cannabis Products Associated with Improvements in Pain, Anxiety, and Depression in Patients with More Severe Symptoms. ” 

3. “Montreal, Canada: The long-term use of CBD-rich cannabis products is associated with overall improvements in patients with moderate to severe anxiety, pain, and depression, according to data published in the Journal of Cannabis Research. ” 

4. “Patients with more severe symptoms exhibited clinical benefits following the use of CBD, whereas those subjects with mild symptoms experienced little overall change in their symptoms. “ ” 

5. “This study on CBD-rich products demonstrates the potential of RWE (real-world evidence) for the advancement of medical cannabis research and practice guidelines, especially in a world where CBD use is exponentially increasing but scientific data are limited. ” 

Source URL: https://norml.org/news/2021/07/01/study-cbd-rich-cannabis-products-associated-with-improvements-in-pain-anxiety-and-depression-in-patients-with-more-severe-symptoms/